TEVA logo

TEVA Change in Working Capital

Latest reported-$1.11B
TEVA Change in Working Capital (-$31.90M → -$1.11B)
High-resolution chart · PNG

TEVA change in working capital history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-1,366,000,000
-435,000,000
-72,000,000
1,355,000,000
-1,701,000,000
-2,188,000,000
-112,000,000
-1,823,000,000
-363,000,000
1,219,000,000
967,000,000
290,000,000
968,000,000
414,000,000
597,000,000
-253,000,000
445,000,000
76,000,000
-854,000,000
-218,000,000
89,000,000
29,600,000
-89,900,000
-141,100,000
-137,197,000
-114,224,000
-52,552,000
-61,000,000
22,600,000
-124,400,000
-3,100,000
-59,400,000
-35,100,000
-26,000,000
-31,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.